2‐Methoxyestradiol inhibits the proliferation level in keloid fibroblasts through p38 in the MAPK /Erk signaling pathway
Journal of Cosmetic Dermatology · 2023
DOI: 10.1111/jocd.15810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Ming-Zi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing, China. Hauptthemen laut MEDLINE: Keloid, Fibroblasts, 2-Methoxyestradiol, MAP Kinase Signaling System. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The MAPK/Erk signaling pathway is a classic pathway in cell proliferation. Our former study showed that keloid tissue revealed a higher proliferation level than physiological scars and normal skin. As a natural metabolite of estradiol, 2‐methoxyestradiol (2ME2) showed an inhibition proliferation effect on tumor cells.
Aim
In this study, the treatment effect of 2ME2 and its potential mechanisms are explored.
Methods
Six keloid patients and six non‐keloid patients were randomly selected from the Department of Plastic Surgery at our hospital during June 2021 to December 2021. Six groups were established: normal skin fibroblasts (N); keloid fibroblasts (K); keloid fibroblasts treated with 2ME2 (K + 2ME2); keloid fibroblasts treated with dimethyl sulfoxide (DMSO) (K + DMSO); keloid fibroblasts treated with doramapimod (K + IN); keloid fibroblasts treated with doramapimod (p38 inhibitor) and 2ME2 (K + IN+2ME2). The fibroblast activity and key factor expression of the MAPK/Erk signaling pathway were measured.
Results
In the results, 2ME2 significantly inhibited keloid fibroblast activity and key factor expression (except STAT1).
Conclusion
The proliferation levels were reduced by both the p38 inhibitor and 2ME2, indicating 2ME2 may achieve an antiproliferation effect by targeting p38 in keloid fibroblasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing, China.
- International Education College, Beijing Vocational College of Agriculture, Beijing, China.
- Department of Planned Immunity, Changjianglu Community Health Center of the West Coast New Area, Qingdao, China.
ORCID-Profile: Yun-Zhu Li, Nan-Ze Yu, Xiao-Jun Wang, Xiao Long
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, M. Z., Liu, Y. F., Ding, L., Li, Z. J., Li, Y. Z., Si, L. B., Yu, N. Z., Wang, X. J., & Long, X. (2023). 2‐Methoxyestradiol inhibits the proliferation level in keloid fibroblasts through p38 in the MAPK /Erk signaling pathway. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15810
Vancouver
Zhang MZ, Liu YF, Ding L, Li ZJ, Li YZ, Si LB, et al. 2‐Methoxyestradiol inhibits the proliferation level in keloid fibroblasts through p38 in the MAPK /Erk signaling pathway. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15810
BibTeX
@article{Zhang2023,
author = {Zhang, Ming-Zi and Liu, Yi-Fang and Ding, Li and Li, Zhi-Jin and Li, Yun-Zhu and Si, Lou-Bin and Yu, Nan-Ze and Wang, Xiao-Jun and Long, Xiao},
title = {2‐Methoxyestradiol inhibits the proliferation level in keloid fibroblasts through p38 in the MAPK /Erk signaling pathway},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
doi = {10.1111/jocd.15810}
}
EUVIMED